These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases. Wang Q, Shaltiel S. BMC Biochem; 2003 Jul 08; 4():5. PubMed ID: 12848892 [Abstract] [Full Text] [Related]
31. Suppression of the facile latency transition of alpha(1)-antitrypsin variant M(malton) by stabilizing mutations. Jung CH, Chae YK, Im H. Biochem Biophys Res Commun; 2004 Dec 17; 325(3):744-50. PubMed ID: 15541353 [Abstract] [Full Text] [Related]
37. The importance of helix F in plasminogen activator inhibitor-1. Vleugels N, Gils A, Bijnens AP, Knockaert I, Declerck PJ. Biochim Biophys Acta; 2000 Jan 03; 1476(1):20-6. PubMed ID: 10606763 [Abstract] [Full Text] [Related]
38. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility. De Taeye B, Gils A, Vleugels N, Rabijns A, Declerck PJ. Biochem Biophys Res Commun; 2004 Aug 27; 321(3):746-51. PubMed ID: 15358169 [Abstract] [Full Text] [Related]
39. Protein conformational change delayed by steric hindrance from an N-linked glycan. Bager R, Johansen JS, Jensen JK, Stensballe A, Jendroszek A, Buxbom L, Sørensen HP, Andreasen PA. J Mol Biol; 2013 Aug 23; 425(16):2867-77. PubMed ID: 23702291 [Abstract] [Full Text] [Related]